IDiyas

For the Inventor, By the Inventor

Arese, Italy

Gunter Thomas

USPTO Granted Patents = 14

Average Co-Inventor Count = 7.7

ph-index = 5

Forward Citations = 341(Granted Patents)


Location History:

  • Milan, IT (1991 - 1993)
  • Arese, IT (1990 - 1995)

Company Filing History:

goldMedal14 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1990-1995

Loading Chart...
14 patents (USPTO):Explore Patents
1. 5470982 - Disubstituted pyridines (1995-11-28),
2. 5401746 - Substituted pyridines heptenoic acid derivatives, useful for treating (1995-03-28),
3. 5177080 - Substituted pyridyl-dihydroxy-heptenoic acid and its salts (1993-01-05),
4. 5173495 - 7-[(2,6-dialkyl-4-furyl or (1992-12-22),
5. 5169857 - 7-(polysubstituted pyridyl)-hept-6-endates useful for treating (1992-12-08),
6. 5164506 - Substituted 2-pyridones and pyrid-2-thiones compounds (1992-11-17),
7. 5145959 - Substituted pyrido (2,3-d) pyrimidines as intermediates (1992-09-08),
8. 5075311 - HMG-CoA reductase inhibiting substituted pryido (2,3-d) pyrimidines (1991-12-24),
9. 5032602 - Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and (1991-07-16),
10. 5006530 - Certain 7-[2,6-diisopropyl-4-phenyl-5-lower (1991-04-09),
11. 4992462 - Substituted pyrroles (1991-02-12),
12. 4988711 - HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles (1991-01-29),
13. 4973598 - Substituted imidazolinones and imidazolinethiones (1990-11-27),
14. 4937255 - Disubstituted pyrroles (1990-06-26),

Title: Innovations in Pharmaceutical Chemistry by Gunter Thomas

Introduction

Gunter Thomas, an accomplished inventor based in Arese, Italy, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 14 patents, Thomas has demonstrated his expertise and commitment to advancing medical treatments through innovative solutions. His work focuses primarily on compounds that target various health conditions, including lipoproteinaemia and arteriosclerosis.

Latest Patents

Among his latest patents, Thomas has developed novel disubstituted pyridines for the treatment of lipoproteinaemia and arteriosclerosis. These innovative compounds, characterized by the formula ##STR1##, feature an optionally substituted aryl or heteroaryl component, showcasing his ability to create effective therapeutic agents. Additionally, he has patented substituted pyridines heptenoic acid derivatives, which serve as valuable tools for treating conditions such as hyperproteinaemia, lipoproteinaemia, or arteriosclerosis, defined under the formula ##STR1## where A, B, D, and E can vary in meaning.

Career Highlights

Gunter Thomas currently works with Bayer Aktiengesellschaft, a global leader in pharmaceuticals and healthcare. His career is marked by his relentless pursuit of innovative solutions to complex health challenges, positioning him as a key player in his industry.

Collaborations

Throughout his career, Thomas has had the opportunity to collaborate with esteemed colleagues such as Rolf Angerbauer and Peter Fey. These partnerships have allowed him to enhance his research and development efforts, leading to breakthroughs in therapeutic innovations.

Conclusion

In summary, Gunter Thomas is a notable inventor whose work is shaping the future of pharmaceutical treatments. His dedication to innovation, backed by a substantial number of patents, exemplifies the impact that skilled inventors can have on the healthcare landscape. With ongoing collaborations and a commitment to excellence, Thomas continues to push the boundaries of what is possible in medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…